These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

104 related articles for article (PubMed ID: 17357536)

  • 81. Reliability of pre-operative biopsies in the histological grading of colorectal adenocarcinomas.
    Burton S; Eddy B; Li WY; Reddy K; Aslam M; Owen E; Weston J
    Ann R Coll Surg Engl; 2003 Jan; 85(1):23-5. PubMed ID: 12585626
    [TBL] [Abstract][Full Text] [Related]  

  • 82. IS THERE A CLINICAL PATHOLOGICAL CORRELATION OF COLORECTAL ADENOCARCINOMA WITH THE IMMUNOHISTOCHEMICAL EXPRESSION OF OPN AND ABCB5?
    Castoldi DF; Malafaia O; Santos-Neto PHD; Postiglioni TV; Vasconcelos C; Bremer FP; Czeczko LEA; Gasser M; Waaga-Gasser AM; Ribas CAPM
    Arq Bras Cir Dig; 2021; 33(4):e1569. PubMed ID: 33759959
    [TBL] [Abstract][Full Text] [Related]  

  • 83. Metalloproteinases and colorectal cancer. Correlation of gene expression and clinical-pathological parameters.
    Morini SR; Denadai MV; Waisberg J; Lopes Filho GJ; Matos D; Saad SS
    Acta Cir Bras; 2020; 35(7):e202000707. PubMed ID: 32813775
    [TBL] [Abstract][Full Text] [Related]  

  • 84. Asprosin, irisin, and meteorin-like protein immunoreactivity in different stages of colorectal adenocarcinoma.
    Uzun M; Ilhan YS; Bozdag A; Yilmaz M; Artas G; Kuloglu T
    Pathol Res Pract; 2023 May; 245():154432. PubMed ID: 37019019
    [TBL] [Abstract][Full Text] [Related]  

  • 85. Investigation of Trpa1 and Trpc1 Immunreactivities in Colon Adenocarcinomas.
    Bozdag A; Kuloglu T; Artas G; Aydin S
    Cancer Manag Res; 2024; 16():377-384. PubMed ID: 38699653
    [TBL] [Abstract][Full Text] [Related]  

  • 86. Low expression of collagen receptors in moderate and poorly differentiated colorectal adenocarcinomas.
    Pignatelli M; Smith ME; Bodmer WF
    Br J Cancer; 1990 Apr; 61(4):636-8. PubMed ID: 2158810
    [No Abstract]   [Full Text] [Related]  

  • 87. The Evaluation of Beta-2-Adrenoreceptors' Expression in Normal Peritumoral Tissue in Patients with Colorectal Adenocarcinoma.
    Florescu C; Târtea GC; Streba CT; Pirici ND; Puiu I; Târtea EA; Ghiluşi M; Comănescu MV; Rogoveanu I; Vere CC
    Curr Health Sci J; 2016; 42(4):335-341. PubMed ID: 30581586
    [TBL] [Abstract][Full Text] [Related]  

  • 88. Immunohistochemical expression of Snail1 protein in colorectal adenocarcinoma samples and its prognostic activity in Caucasian patients.
    Brzozowa-Zasada M
    Prz Gastroenterol; 2021; 16(4):339-345. PubMed ID: 34976242
    [TBL] [Abstract][Full Text] [Related]  

  • 89. Clinicopathological characteristics of co-existing or mixed colorectal cancer and neuroendocrine tumor: Report of five cases.
    Zhang L; Wang X; Wang Y; Zeng Y; Li L
    Open Life Sci; 2023; 18(1):20220774. PubMed ID: 38152582
    [TBL] [Abstract][Full Text] [Related]  

  • 90. Tissue sampling and histological grading in colorectal cancer. Are routine sections representative?
    Halvorsen TB
    APMIS; 1989 Mar; 97(3):261-6. PubMed ID: 2653384
    [TBL] [Abstract][Full Text] [Related]  

  • 91. Colorectal cancers of rare histologic types compared with adenocarcinomas.
    DiSario JA
    Dis Colon Rectum; 1995 Nov; 38(11):1227. PubMed ID: 7587771
    [No Abstract]   [Full Text] [Related]  

  • 92. Discovery of genes from feces correlated with colorectal cancer progression.
    Lee CL; Huang CJ; Yang SH; Chang CC; Huang CC; Chien CC; Yang RN
    Oncol Lett; 2016 Nov; 12(5):3378-3384. PubMed ID: 27900008
    [TBL] [Abstract][Full Text] [Related]  

  • 93. Efficacy of Immunohistochemical Staining in Differentiating a Squamous Cell Carcinoma in Poorly Differentiated Rectal Cancer: Two Case Reports.
    Rami S; Han YD; Jang M; Cho MS; Hur H; Min BS; Lee KY; Kim NK
    Ann Coloproctol; 2016 Aug; 32(4):150-5. PubMed ID: 27626026
    [TBL] [Abstract][Full Text] [Related]  

  • 94. Expression of cyclooxygenase-2 (COX-2) in colorectal adenocarcinoma: an immunohistochemical and histopathological study.
    Mahmoud AS; Umair A; Azzeghaiby SN; Alqahtani FH; Hanouneh S; Tarakji B
    Asian Pac J Cancer Prev; 2014; 15(16):6787-90. PubMed ID: 25169526
    [TBL] [Abstract][Full Text] [Related]  

  • 95. Correlation of COX- 2 Expression in Colorectal Carcinoma with Clinicopathological Features.
    Venkatachala S; Rajendran M
    Turk Patoloji Derg; 2017; 33(3):228-234. PubMed ID: 28272681
    [TBL] [Abstract][Full Text] [Related]  

  • 96. 5-Lipoxygenase is coexpressed with Cox-2 in sporadic colorectal cancer: a correlation with advanced stage.
    Barresi V; Grosso M; Vitarelli E; Tuccari G; Barresi G
    Dis Colon Rectum; 2007 Oct; 50(10):1576-84. PubMed ID: 17762961
    [TBL] [Abstract][Full Text] [Related]  

  • 97. Tissue microarray-determined expression profiles of cyclooxygenase-2 in colorectal adenocarcinoma: association with clinicopathological parameters.
    Wu CY; Lee WH; Wang JY; Chiang H; Chang JL; Tsai WC; Sheu LF; Jin JS
    Chin J Physiol; 2006 Dec; 49(6):298-304. PubMed ID: 17357536
    [TBL] [Abstract][Full Text] [Related]  

  • 98. Higher expression of epidermal growth factor receptor is associated with extracellular matrix metalloprotease inducer in colorectal adenocarcinoma: tissue microarray analysis of immunostaining score with clinicopathological parameters.
    Jin JS; Wu CY; Lin YF; Wang JY; Yu CP; Sheu LF; Chiang H; Tsai WC; Lee WH
    Dis Markers; 2006; 22(5-6):309-16. PubMed ID: 17264401
    [TBL] [Abstract][Full Text] [Related]  

  • 99.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

  • 100.
    ; ; . PubMed ID:
    [No Abstract]   [Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 6.